TITLE

MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism

PUB. DATE
January 2008
SOURCE
BMC Genetics;2008, Vol. 9, p281
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
43749493

 

Related Articles

  • MDM2 SNP309 polymorphism is associated with colorectal cancer risk. Weizhi Wang; Mulong Du; Dongying Gu; Lingjun Zhu; Haiyan Chu; Na Tong; Zhengdong Zhang; Zekuan Xu; Meilin Wang // Scientific Reports;5/9/2014, p1 

    The human murine double minute 2 (MDM2) is known as an oncoprotein through inhibiting P53 transcriptional activity and mediating P53 ubiquitination. Therefore, the amplification of MDM2 may attenuate the P53 pathway and promote tumorigenesis. The SNP309 T>G polymorphism (rs2279744), which is...

  • MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk. Knappskog, Stian; Gansmo, Liv B.; Romundstad, P�l; Bj�rnslett, Merete; Trovik, Jone; Sommerfelt-Pettersen, Jan; L�kkevik, Erik; Tollenaar, Rob A. E. M.; Seynaeve, Caroline; Devilee, Peter; Salvesen, Helga B.; D�rum, Anne; Hveem, Kristian; Vatten, Lars; L�nning, Per E. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    The MDM2 proto-oncogene plays a key role in central cellular processes like growth control and apoptosis, and the gene locus is frequently amplified in sarcomas. Two polymorphisms located in the MDM2 promoter P2 have been shown to affect cancer risk. One of these polymorphisms (SNP309T.G;...

  • MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk. Knappskog, Stian; Gansmo, Liv B.; Romundstad, Pål; Bjørnslett, Merete; Trovik, Jone; Sommerfelt-Pettersen, Jan; Løkkevik, Erik; Tollenaar, Rob A. E. M.; Seynaeve, Caroline; Devilee, Peter; Salvesen, Helga B.; Dørum, Anne; Hveem, Kristian; Vatten, Lars; Lønning, Per E. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    The MDM2 proto-oncogene plays a key role in central cellular processes like growth control and apoptosis, and the gene locus is frequently amplified in sarcomas. Two polymorphisms located in the MDM2 promoter P2 have been shown to affect cancer risk. One of these polymorphisms (SNP309T.G;...

  • Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA½ mutations. Nechushtan, Hovav; Hamburger, Tamar; Mendelson, Susan; Kadouri, Luna; Sharon, Nir; Pikarsky, Eli; Peretz, Tamar // BMC Cancer;2009, Vol. 9, Special section p1 

    Background: A germ line single nucleotide polymorphism (SNP) in the first intron of the gene encoding MDM2 at position 309, an important modulator of p53, has been described. BRCA1/2 mutation have been associated with increased rates of breast cancers with mutated P53. It was shown that the...

  • Lack of Association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults. Onel, K. B.; Huo, D.; Hastings, D.; Fryer-Biggs, J.; Crow, M. K.; Onel, K. // Lupus;Jan2009, Vol. 18 Issue 1, p61 

    The p53 tumour suppressor is the central regulator of apoptosis. Previously, the functional TP53 Arg72Pro polymorphism was found to be associated with systemic lupus erythematosus (SLE) in Koreans but not Spaniards. MDM2 is the major negative regulator of p53. An intronic polymorphism in MDM2,...

  • Endogenous Human MDM2-C Is Highly Expressed in Human Cancers and Functions as a p53-Independent Growth Activator. Okoro, Danielle R.; Arva, Nicoleta; Gao, Chong; Polotskaia, Alla; Puente, Cindy; Rosso, Melissa; Bargonetti, Jill // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Human cancers over-expressing mdm2, through a T to G variation at a single nucleotide polymorphism at position 309 (mdm2 SNP309), have functionally inactivated p53 that is not effectively degraded. They also have high expression of the alternatively spliced transcript, mdm2-C. Alternatively...

  • DISRUPTION OF THE P53-MDM2 COMPLEX BY NUTLIN-3 REVEALS DIFFERENT CANCER CELL PHENOTYPES. Arva, Nicoleta C.; Talbott, Kathryn E.; Okoro, Danielle R.; Brekman, Angelika; Wei Gang Qiu; Bargonetti, Jill // Ethnicity & Disease;Spring2008 Supplement2, Vol. 18, pS2:1 

    Introduction: Mdm2 inhibits p53 transactivation by forming a p53-Mdm2 complex on chromatin. Upon DNA damage-induced complex disruption, such latent p53 can be activated, but in cells overexpressing Mdm2 because of a homozygous single nucleotide polymorphism at position 309 (T→G) ofmdm2,...

  • Association of MDM2 and p53 Polymorphisms with the Advancement of Cervical Carcinoma. Singhal, Pallavi; Hussain, Showket; Thakur, Nisha; Batra, Swaraj; Salhan, Sudha; Bhambani, Suresh; Bharadwaj, Mausumi // DNA & Cell Biology;Jan2013, Vol. 32 Issue 1, p19 

    Cervical cancer is one of the most common gynecological malignancies that causes a serious health problem worldwide. The aim of the present study was to analyze the association of p53 codon72 (arginine/proline) polymorphism (rs1042522) and Murine Double Minute 2 ( MDM2) SNP309 T/G (rs2279744)...

  • LETTER TO THE EDITOR REPLY. ZAJĄC, AGNIESZKA; STACHOWIAK, GRZEGORZ; PERTYŃSKI, TOMASZ; ROMANOWICZ, HANNA; WILCZYŃSKI, JACEK; SMOLARZ, BEATA // Polish Journal of Pathology: Official Journal of the Polish Soci;2013, Issue 1, p70 

    A response from the authors of the article "Association Between MDM2 SNP309 Polymorphism and Endometrial Cancer Risk in Polish Women," that was published in a previous issue is presented.

  • MDM2 SNP309 and risk of endometrial cancer. KNAPPSKOG, STIAN; LØNNING, PER EYSTEIN // Polish Journal of Pathology: Official Journal of the Polish Soci;2013, Issue 1, p69 

    A letter to the editor is presented in response to the article "Association Between MDM2 SNP309 Polymorphism and Endometrial Cancer Risk in Polish Women," that was published in a previous issue.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics